These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 39082260)

  • 1. Dynamic pattern of postprandial bile acids in paediatric non-alcoholic fatty liver disease.
    Huang J; Lin H; Liu AN; Wu W; Alisi A; Loomba R; Xu C; Xiang W; Shao J; Dong G; Zheng MH; Fu J; Ni Y
    Liver Int; 2024 Oct; 44(10):2793-2806. PubMed ID: 39082260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial.
    Friedrich D; Marschall HU; Lammert F
    BMC Gastroenterol; 2018 Jun; 18(1):76. PubMed ID: 29866129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease.
    Mouzaki M; Wang AY; Bandsma R; Comelli EM; Arendt BM; Zhang L; Fung S; Fischer SE; McGilvray IG; Allard JP
    PLoS One; 2016; 11(5):e0151829. PubMed ID: 27203081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Changes of Bile Acids and FGF19 After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass.
    Chen Y; Lu J; Nemati R; Plank LD; Murphy R
    Obes Surg; 2019 Nov; 29(11):3605-3621. PubMed ID: 31273649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-alcoholic fatty liver disease is associated with dysregulated bile acid synthesis and diarrhea: A prospective observational study.
    Appleby RN; Moghul I; Khan S; Yee M; Manousou P; Neal TD; Walters JRF
    PLoS One; 2019; 14(1):e0211348. PubMed ID: 30682184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise training and diet-induced weight loss increase markers of hepatic bile acid (BA) synthesis and reduce serum total BA concentrations in obese women.
    Mercer KE; Maurer A; Pack LM; Ono-Moore K; Spray BJ; Campbell C; Chandler CJ; Burnett D; Souza E; Casazza G; Keim N; Newman J; Hunter G; Fernadez J; Garvey WT; Harper ME; Hoppel C; Adams SH; Thyfault J
    Am J Physiol Endocrinol Metab; 2021 May; 320(5):E864-E873. PubMed ID: 33645254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NASH-related increases in plasma bile acid levels depend on insulin resistance.
    Grzych G; Chávez-Talavera O; Descat A; Thuillier D; Verrijken A; Kouach M; Legry V; Verkindt H; Raverdy V; Legendre B; Caiazzo R; Van Gaal L; Goossens JF; Paumelle R; Francque S; Pattou F; Haas JT; Tailleux A; Staels B
    JHEP Rep; 2021 Apr; 3(2):100222. PubMed ID: 33615207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender-Specific Bile Acid Profiles in Non-Alcoholic Fatty Liver Disease.
    Fitzinger J; Rodriguez-Blanco G; Herrmann M; Borenich A; Stauber R; Aigner E; Mangge H
    Nutrients; 2024 Jan; 16(2):. PubMed ID: 38257143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis.
    Luo Y; Decato BE; Charles ED; Shevell DE; McNaney C; Shipkova P; Apfel A; Tirucherai GS; Sanyal AJ
    JHEP Rep; 2022 Jan; 4(1):100392. PubMed ID: 34977519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance.
    Schreuder TC; Marsman HA; Lenicek M; van Werven JR; Nederveen AJ; Jansen PL; Schaap FG
    Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G440-5. PubMed ID: 20093562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Associations between Circulating Bile Acids and the Muscle Volume in Patients with Non-alcoholic Fatty Liver Disease (NAFLD).
    Kobayashi Y; Hara N; Sugimoto R; Mifuji-Moroka R; Tanaka H; Eguchi A; Iwasa M; Hasegawa H; Iwata K; Takei Y; Taguchi O
    Intern Med; 2017; 56(7):755-762. PubMed ID: 28381740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD.
    Jiao N; Baker SS; Chapa-Rodriguez A; Liu W; Nugent CA; Tsompana M; Mastrandrea L; Buck MJ; Baker RD; Genco RJ; Zhu R; Zhu L
    Gut; 2018 Oct; 67(10):1881-1891. PubMed ID: 28774887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Bile Acid Levels in Children With Nonalcoholic Fatty Liver Disease.
    Jahnel J; Zöhrer E; Alisi A; Ferrari F; Ceccarelli S; De Vito R; Scharnagl H; Stojakovic T; Fauler G; Trauner M; Nobili V
    J Pediatr Gastroenterol Nutr; 2015 Jul; 61(1):85-90. PubMed ID: 25729888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lowered fasting chenodeoxycholic acid correlated with the decrease of fibroblast growth factor 19 in Chinese subjects with impaired fasting glucose.
    Zhang J; Li H; Zhou H; Fang L; Xu J; Yan H; Chen S; Song Q; Zhang Y; Xu A; Fang Q; Ye Y; Jia W
    Sci Rep; 2017 Jul; 7(1):6042. PubMed ID: 28729691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum bile acid level and fatty acid composition in Chinese children with non-alcoholic fatty liver disease.
    Lu LP; Wan YP; Xun PC; Zhou KJ; Chen C; Cheng SY; Zhang MZ; Wu CH; Lin WW; Jiang Y; Feng HX; Wang JL; He K; Cai W
    J Dig Dis; 2017 Aug; 18(8):461-471. PubMed ID: 28585279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asynchronous rhythms of circulating conjugated and unconjugated bile acids in the modulation of human metabolism.
    Al-Khaifi A; Straniero S; Voronova V; Chernikova D; Sokolov V; Kumar C; Angelin B; Rudling M
    J Intern Med; 2018 Nov; 284(5):546-559. PubMed ID: 29964306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.
    Gillard J; Clerbaux LA; Nachit M; Sempoux C; Staels B; Bindels LB; Tailleux A; Leclercq IA
    JHEP Rep; 2022 Jan; 4(1):100387. PubMed ID: 34825156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile acids associate with glucose metabolism, but do not predict conversion from impaired fasting glucose to diabetes.
    Chávez-Talavera O; Wargny M; Pichelin M; Descat A; Vallez E; Kouach M; Bigot-Corbel E; Joliveau M; Goossens JF; Le May C; Hadjadj S; Hanf R; Tailleux A; Staels B; Cariou B
    Metabolism; 2020 Feb; 103():154042. PubMed ID: 31785259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression.
    Nimer N; Choucair I; Wang Z; Nemet I; Li L; Gukasyan J; Weeks TL; Alkhouri N; Zein N; Tang WHW; Fischbach MA; Brown JM; Allayee H; Dasarathy S; Gogonea V; Hazen SL
    Metabolism; 2021 Mar; 116():154457. PubMed ID: 33275980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes.
    Calderon G; McRae A; Rievaj J; Davis J; Zandvakili I; Linker-Nord S; Burton D; Roberts G; Reimann F; Gedulin B; Vella A; LaRusso NF; Camilleri M; Gribble FM; Acosta A
    EBioMedicine; 2020 May; 55():102759. PubMed ID: 32344198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.